Aurobindo Pharma gets USFDA's approval forDuloxetine

 The US Food and Drug Administration(USFDA) has given its nod to Aurobindo Pharma Ltd to produce and market Duloxetine Hydrochloride delayed-release capsules 20mg (base), 30mg (base) and 60mg (base).